Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 275


Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.

Columba-Cabezas S, Griguoli M, Rosicarelli B, Magliozzi R, Ria F, Serafini B, Aloisi F.

J Neuroimmunol. 2006 Oct;179(1-2):76-86. Epub 2006 Jul 25.


Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice.

Gatumu MK, Skarstein K, Papandile A, Browning JL, Fava RA, Bolstad AI.

Arthritis Res Ther. 2009;11(1):R24. doi: 10.1186/ar2617. Epub 2009 Feb 18.


IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.

Klein RS, Izikson L, Means T, Gibson HD, Lin E, Sobel RA, Weiner HL, Luster AD.

J Immunol. 2004 Jan 1;172(1):550-9.


Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases.

Armengol MP, Cardoso-Schmidt CB, Fernández M, Ferrer X, Pujol-Borrell R, Juan M.

J Immunol. 2003 Jun 15;170(12):6320-8.


B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion.

Yu P, Wang Y, Chin RK, Martinez-Pomares L, Gordon S, Kosco-Vibois MH, Cyster J, Fu YX.

J Immunol. 2002 May 15;168(10):5117-23.


Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.

Whitham RH, Wingett D, Wineman J, Mass M, Wegmann K, Vandenbark A, Offner H.

J Neurosci Res. 1996 Jul 15;45(2):104-16.


Altered peptide ligand modulation of experimental allergic encephalomyelitis: immune responses within the CNS.

Santambrogio L, Lees MB, Sobel RA.

J Neuroimmunol. 1998 Jan;81(1-2):1-13.


Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.

Huan J, Subramanian S, Jones R, Rich C, Link J, Mooney J, Bourdette DN, Vandenbark AA, Burrows GG, Offner H.

J Immunol. 2004 Apr 1;172(7):4556-66.


De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.

Tompkins SM, Padilla J, Dal Canto MC, Ting JP, Van Kaer L, Miller SD.

J Immunol. 2002 Apr 15;168(8):4173-83.


Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation--opposite functions for surface lymphotoxin expressed by T and B lymphocytes.

Jungbeck M, Stopfer P, Bataille F, Nedospasov SA, Männel DN, Hehlgans T.

Mol Immunol. 2008 Jan;45(1):34-41. Epub 2007 Jun 27.


Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.

Howard LM, Miga AJ, Vanderlugt CL, Dal Canto MC, Laman JD, Noelle RJ, Miller SD.

J Clin Invest. 1999 Jan;103(2):281-90.


IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.

Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, Sakaguchi S, Kuchroo VK, Weiner HL.

Int Immunol. 2004 Feb;16(2):249-56.


A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis.

Fava RA, Notidis E, Hunt J, Szanya V, Ratcliffe N, Ngam-Ek A, De Fougerolles AR, Sprague A, Browning JL.

J Immunol. 2003 Jul 1;171(1):115-26.


Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells.

Endres R, Alimzhanov MB, Plitz T, Fütterer A, Kosco-Vilbois MH, Nedospasov SA, Rajewsky K, Pfeffer K.

J Exp Med. 1999 Jan 4;189(1):159-68.

Supplemental Content

Support Center